NO20023006L - Virulens gener, proteiner og deres anvendelse - Google Patents

Virulens gener, proteiner og deres anvendelse

Info

Publication number: NO20023006L
Authority: NO; Norway
Prior art keywords: genes; proteins; viral genes; products; virulence
Prior art date: 1999-12-23

Application number

NO20023006A

Other languages

English (en)

Other versions

NO20023006D0 (no

Inventor

Enda Elizabeth Clarke

Liqing Zhou

Jacqueline Elizabeth Shea

Robert Graham Feldman

David William Holden

Original Assignee

Vmax Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2002-06-21

Publication date

2002-06-21

1999-12-23 Priority claimed from GBGB9930474.3A external-priority patent/GB9930474D0/en

1999-12-23 Priority claimed from GBGB9930471.9A external-priority patent/GB9930471D0/en

1999-12-23 Priority claimed from GBGB9930476.8A external-priority patent/GB9930476D0/en

1999-12-23 Priority claimed from GBGB9930466.9A external-priority patent/GB9930466D0/en

1999-12-23 Priority claimed from GBGB9930475.0A external-priority patent/GB9930475D0/en

1999-12-23 Priority claimed from GBGB9930467.7A external-priority patent/GB9930467D0/en

1999-12-23 Priority claimed from GBGB9930462.8A external-priority patent/GB9930462D0/en

1999-12-23 Priority claimed from GBGB9930469.3A external-priority patent/GB9930469D0/en

1999-12-23 Priority claimed from GBGB9930472.7A external-priority patent/GB9930472D0/en

1999-12-23 Priority claimed from GBGB9930463.6A external-priority patent/GB9930463D0/en

1999-12-23 Priority claimed from GBGB9930473.5A external-priority patent/GB9930473D0/en

1999-12-23 Priority claimed from GBGB9930464.4A external-priority patent/GB9930464D0/en

2000-02-17 Priority claimed from GB0003732A external-priority patent/GB0003732D0/en

2000-02-17 Priority claimed from GB0003727A external-priority patent/GB0003727D0/en

2000-02-17 Priority claimed from GB0003736A external-priority patent/GB0003736D0/en

2000-02-17 Priority claimed from GB0003728A external-priority patent/GB0003728D0/en

2000-02-17 Priority claimed from GB0003730A external-priority patent/GB0003730D0/en

2000-02-17 Priority claimed from GB0003726A external-priority patent/GB0003726D0/en

2000-02-17 Priority claimed from GB0003735A external-priority patent/GB0003735D0/en

2000-02-17 Priority claimed from GB0003733A external-priority patent/GB0003733D0/en

2000-02-17 Priority claimed from GB0003731A external-priority patent/GB0003731D0/en

2000-02-17 Priority claimed from GB0003725A external-priority patent/GB0003725D0/en

2000-02-17 Priority claimed from GB0003729A external-priority patent/GB0003729D0/en

2000-05-02 Priority claimed from GB0010585A external-priority patent/GB0010585D0/en

2000-05-02 Priority claimed from GB0010587A external-priority patent/GB0010587D0/en

2002-06-21 Publication of NO20023006L publication Critical patent/NO20023006L/no

2002-06-21 Application filed by Vmax Ltd filed Critical Vmax Ltd

2002-06-21 Publication of NO20023006D0 publication Critical patent/NO20023006D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO22000GBW00/A 1999-12-23 2002-06-21 Virulens gener, proteiner og deres anvendelse NO20023006D0 (no)

Applications Claiming Priority (26)

Application Number	Priority Date	Filing Date	Title
GBGB9930466.9A GB9930466D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930475.0A GB9930475D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930467.7A GB9930467D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930462.8A GB9930462D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein and their use
GBGB9930469.3A GB9930469D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930472.7A GB9930472D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930463.6A GB9930463D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein and their use
GBGB9930473.5A GB9930473D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein, and their use
GBGB9930464.4A GB9930464D0 (en)	1999-12-23	1999-12-23	Virullence gene and protein and their use
GBGB9930476.8A GB9930476D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930471.9A GB9930471D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein,and their use
GBGB9930474.3A GB9930474D0 (en)	1999-12-23	1999-12-23	Virulence gene and protein, and their use
GB0003728A GB0003728D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0003730A GB0003730D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0003726A GB0003726D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein and their use
GB0003736A GB0003736D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, an their use
GB0003727A GB0003727D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein and their use
GB0003731A GB0003731D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0003725A GB0003725D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein and their use
GB0003729A GB0003729D0 (en)	2000-02-17	2000-02-17	Virulene gene and protein, and their use
GB0003733A GB0003733D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0003735A GB0003735D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0003732A GB0003732D0 (en)	2000-02-17	2000-02-17	Virulence gene and protein, and their use
GB0010587A GB0010587D0 (en)	2000-05-02	2000-05-02	Virulence gene and protein, and their use
GB0010585A GB0010585D0 (en)	2000-05-02	2000-05-02	Virulence gene and protein, and their use
PCT/GB2000/004997 WO2001048208A2 (en)	1999-12-23	2000-12-22	Streptococcus pyogenes virulence genes and proteins and their use

Publications (2)

Publication Number	Publication Date
NO20023006L true NO20023006L (no)	2002-06-21
NO20023006D0 NO20023006D0 (no)	2002-06-21

Family

ID=27586758

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO22000GBW00/A NO20023006D0 (no)	1999-12-23	2002-06-21	Virulens gener, proteiner og deres anvendelse

Country Status (12)

Country	Link
US (2)	US6951732B2 (no)
EP (2)	EP1905834A3 (no)
JP (1)	JP2003520034A (no)
KR (1)	KR20020073150A (no)
AT (1)	ATE384797T1 (no)
AU (1)	AU775385B2 (no)
CA (1)	CA2397710A1 (no)
HK (1)	HK1048134B (no)
HU (1)	HUP0203880A2 (no)
NO (1)	NO20023006D0 (no)
NZ (1)	NZ519669A (no)
WO (1)	WO2001048208A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ296981B6 (cs) *	1994-12-09	2006-08-16	Imperial College Innovations Limited	Zpusob pro identifikaci mikroorganizmu, zpusob identifikování genu, mikroorganizmus, vakcína a zpusob její prípravy, zpusob získání mutantního mikroorganizmu, zpusob prípravy farmaceutického prostredku, zpusob identifikace slouceniny a zpusob príprav
AU5860599A (en) *	1998-09-04	2000-03-27	Creatogen Aktiengesellschaft	Attenuated salmonella spi2 mutants as antigen carriers
GB9910812D0 (en) *	1999-05-10	1999-07-07	Microscience Ltd	Vaccine composition
WO2006048753A2 (en) *	2004-11-05	2006-05-11	Pharmacia & Upjohn Company Llc	Anti-bacterial vaccine compositions
WO2006048757A2 (en) *	2004-11-05	2006-05-11	Pharmacia & Upjohn Company Llc	Anti-bacterial vaccine compositions
GB2428006A (en) *	2005-07-07	2007-01-17	Jevgenis Morov	AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
WO2009158240A1 (en)	2008-06-16	2009-12-30	Emergent Product Development Uk Limited	Salmonella vectored vaccines against chlamydia and methods of use
EP2135877A1 (en)	2008-06-19	2009-12-23	Helmholtz-Zentrum für Infektionsforschung GmbH	Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
US10105412B2 (en) *	2009-06-29	2018-10-23	Genocea Biosciences, Inc.	Vaccines and compositions against Streptococcus pneumoniae
EP2665490B1 (en)	2011-01-20	2020-03-04	Genocea Biosciences, Inc.	Vaccines and compositions against streptococcus pneumoniae

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9503495L (sv)	1995-10-09	1997-04-10	Actinova Ltd	Nytt protein
US6737248B2 (en)	1996-01-05	2004-05-18	Human Genome Sciences, Inc.	Staphylococcus aureus polynucleotides and sequences
US6346392B1 (en) *	1996-11-27	2002-02-12	Smithkline Beecham Corporation	Polynucleotides encoding a novel glutamine transport ATP-binding protein
ATE348887T1 (de) *	1996-10-31	2007-01-15	Human Genome Sciences Inc	Streptococcus pneumoniae antigene und impfstoffe
NZ560966A (en) *	2000-10-27	2010-06-25	Novartis Vaccines & Diagnostic	Nucleic acids and proteins from streptococcus groups A & B

2000
- 2000-12-22 EP EP07119228A patent/EP1905834A3/en not_active Withdrawn
- 2000-12-22 CA CA002397710A patent/CA2397710A1/en not_active Abandoned
- 2000-12-22 AU AU23823/01A patent/AU775385B2/en not_active Ceased
- 2000-12-22 US US10/169,048 patent/US6951732B2/en not_active Expired - Fee Related
- 2000-12-22 EP EP00987575A patent/EP1240332B1/en not_active Expired - Lifetime
- 2000-12-22 NZ NZ519669A patent/NZ519669A/en unknown
- 2000-12-22 WO PCT/GB2000/004997 patent/WO2001048208A2/en active IP Right Grant
- 2000-12-22 KR KR1020027008093A patent/KR20020073150A/ko not_active Application Discontinuation
- 2000-12-22 HU HU0203880A patent/HUP0203880A2/hu unknown
- 2000-12-22 JP JP2001548721A patent/JP2003520034A/ja active Pending
- 2000-12-22 AT AT00987575T patent/ATE384797T1/de not_active IP Right Cessation
2002
- 2002-06-21 NO NO22000GBW00/A patent/NO20023006D0/no not_active Application Discontinuation
- 2002-11-21 HK HK02108435.4A patent/HK1048134B/zh not_active IP Right Cessation
2005
- 2005-06-03 US US11/144,352 patent/US20050232942A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1240332A2 (en)	2002-09-18
WO2001048208A3 (en)	2001-12-20
JP2003520034A (ja)	2003-07-02
AU2382301A (en)	2001-07-09
EP1240332B1 (en)	2008-01-23
HK1048134A1 (en)	2003-03-21
ATE384797T1 (de)	2008-02-15
HK1048134B (zh)	2008-09-05
CA2397710A1 (en)	2001-07-05
US20050232942A1 (en)	2005-10-20
NO20023006D0 (no)	2002-06-21
EP1905834A3 (en)	2008-07-23
US20030072769A1 (en)	2003-04-17
NZ519669A (en)	2004-03-26
WO2001048208A2 (en)	2001-07-05
KR20020073150A (ko)	2002-09-19
US6951732B2 (en)	2005-10-04
EP1905834A2 (en)	2008-04-02
AU775385B2 (en)	2004-07-29
HUP0203880A2 (hu)	2003-03-28

Publication	Publication Date	Title
NO983876L (no)	1998-10-21	Syntetiske HIV-gener
NO20025329D0 (no)	2002-11-06	Virulensgener, proteiner og deres anvendelse
CY1111771T1 (el)	2015-10-07	Ενζυμα τα οποια εχουν δραστικοτητα αλφα αμυλασης και μεθοδοι χρησεις τους
NO20110429L (no)	2003-08-21	Polypeptider og nukleinsyre-DNA for anvendelse innen medisin
NO20041157L (no)	2004-05-19	HIV-GAG kodonoptimaliserte DNA-vaksiner
NO20023006D0 (no)	2002-06-21	Virulens gener, proteiner og deres anvendelse
DK1854809T3 (da)	2013-01-21	Nukleinsyre og tilsvarende protein betegnet 158P1D7, der er anvendelig i behandling og påvisning af blærecancer og andre cancere
ATE103331T1 (de)	1994-04-15	Vakzine.
MXPA05005202A (es)	2006-01-27	Vacuna.
DK1154791T3 (da)	2008-06-16	Neisseria-vaccinesammensætninger og fremgangsmåder
NO20013102D0 (no)	2001-06-21	Gener, proteiner og deres anvendelse
NO983946D0 (no)	1998-08-27	Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
ATE310085T1 (de)	2005-12-15	Cyclin-e2 proteine und dafür kodierende gene
NZ511366A (en)	2004-03-26	Virulence genes and proteins, and their use
NO20003146L (no)	2000-06-26	Ketonperoksyd-derivater, deres fremstilling og anvendelse
WO2003000930A3 (en)	2003-10-16	Nucleotide sequences involved in plant disease resistance
WO2003044047A3 (en)	2003-12-18	Virulence proteins of the genus yersinia and uses thereof
DE60126765D1 (de)	2007-04-05	Virulenz gene, proteine, und ihre verwendung
DK1313850T3 (da)	2008-12-01	Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
NO20013101L (no)	2001-08-13	Ytre overflateproteiner, deres gener og deres anvendelse
WO2001057075A3 (en)	2002-01-31	Virulence genes, proteins, and their use
WO2002016612A3 (en)	2003-10-09	Genes and proteins, and their uses
DE602005020915D1 (de)	2010-06-10	Mannose-spezifische adhesinen und deren vervendung
DK0980379T3 (da)	2002-12-02	Chimære oligonucleotider og deres anvendelse
WO2002077020A3 (en)	2003-06-19	Virulence genes in h. influenzae

Legal Events

Date	Code	Title	Description
2009-12-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application